Electrochemical Biosensing for Clinical Diagnostics and Biomarker Detection

Electrochemical biosensing merges the specificity of biological recognition elements with the sensitivity of electrochemical transduction to quantify clinically relevant molecules. By immobilising enzymes, antibodies or aptamers on electrode surfaces, these sensors convert biochemical interactions into electrical signals—typically current, potential or resistance changes. Advances in materials science have driven the incorporation of nanostructured films, composites and three-dimensional electrode architectures, significantly boosting active surface area, electron transfer kinetics and sensor stability. This progress enables detection of biomarkers at concentrations from micromolar down to attomolar levels, supporting early diagnosis of diseases such as cancer, cardiovascular disorders and neurological conditions. The integration of portable platforms, wearable formats and microfluidic channels further extends the reach of electrochemical biosensors into point-of-care and real-time monitoring. Overall, the field is advancing towards robust, multiplexed devices that offer rapid, cost-effective analysis with minimal sample preparation, promising transformative impact on global health.

Research from Nature Portfolio

Recent studies have demonstrated a hierarchical electrode architecture achieved through additive manufacturing of silver micropillars decorated with graphene nanoflakes. This multi-length-scale design harnesses nanoscale graphene for high specific surface area and microscale pillars to accelerate analyte diffusion, yielding a limit of detection in the attomole range for neurotransmitters such as dopamine. The work illustrates how coupling 3D printing and nanomaterial engineering can overcome conventional sensitivity barriers and paves the way for ultrasensitive detection of low-abundance biomarkers in complex biological matrices.

Electrochemical Biosensing for Clinical Diagnostics and Biomarker Detection publication trend

The graph below shows the total number of articles in electrochemical biosensing for clinical diagnostics and biomarker detection across all publications each year (not limited to Nature Index journals).

Technical terms

Electrochemical biosensor: A sensing device that combines a biological recognition element with an electrode to generate an electrical signal proportional to analyte concentration.

Amperometry: A technique in which current is measured at a fixed potential to quantify the concentration of an electroactive species.

Potentiometric sensor: A device that measures the potential difference between a working and a reference electrode under near-zero current conditions to infer analyte activity.

Chemiresistive sensor: A sensor in which the electrical resistance of a sensing film changes upon interaction with a target analyte.

Hierarchical electrode architecture: A multiscale electrode design combining micro- and nanostructures to maximise surface area and mass-transport efficiency.

Limit of detection (LOD): The lowest analyte concentration that can be reliably distinguished from background noise under specified conditions.

Nanocomposite: A material composed of two or more constituents, with at least one component at the nanoscale, engineered to enhance functional properties.

References

1. Breaking the barrier to biomolecule limit-of-detection via 3D printed multi-length-scale graphene-coated electrodes. Nature Communications (2021).
2. Sarcosine Biosensor Based on Pt/g-C3N4 Nanocomposites with High Electrocatalytic Activity. ECS Journal of Solid State Science and Technology (2022).
3. A Flexible and Wearable Chemiresistive Biosensor Fabricated by Laser Inducing for Real‐Time Glucose Analysis of Sweat. Advanced Materials Interfaces (2023).